PI3King the Environment for Growth: PI3K Activation Drives Transcriptome Changes That Support Oncogenic Growth
PI3K signaling plays an integral role in cells, coordinating the necessary alterations in cellular metabolism and programs to support survival and proliferation. In the first genome-wide analysis of alternative splicing in PIK3CA-mutant breast cancer, Ladewig and colleagues show that activating muta...
Gespeichert in:
Veröffentlicht in: | Cancer research (Chicago, Ill.) Ill.), 2022-06, Vol.82 (12), p.2216-2218 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2218 |
---|---|
container_issue | 12 |
container_start_page | 2216 |
container_title | Cancer research (Chicago, Ill.) |
container_volume | 82 |
creator | Claridge, Sally E Hopkins, Benjamin D |
description | PI3K signaling plays an integral role in cells, coordinating the necessary alterations in cellular metabolism and programs to support survival and proliferation. In the first genome-wide analysis of alternative splicing in PIK3CA-mutant breast cancer, Ladewig and colleagues show that activating mutations in PIK3CA alter the use of known exons and splice junctions, leading to changes in gene expression and transcription factor activity that promote an oncogenic phenotype. Their work reveals a novel mechanism underlying the functional impact of PI3K signal activation in the context of breast cancer, where PIK3CA mutations are common and PI3K inhibitors are part of the standard of care. Their studies uncover a feedforward mechanism by which PI3K signaling enables a shift in the spectrum of translated splice variants as another method through which the PI3K pathway has evolved to regulate its own activity, thereby modifying the cellular response to upstream activation based on the signaling that has come before. These findings have profound implications for understanding the evolution of the PI3K pathway and the rewiring of cells in response to prolonged or repeated signal activation. See related article by Ladewig et al., p. 2269. |
doi_str_mv | 10.1158/0008-5472.CAN-22-1466 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10309115</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2676922275</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3276-ea583c44b2276915890dc1a3bba3f93b4106b90091f1ee9ac1b16858d5ff9de43</originalsourceid><addsrcrecordid>eNpVkV9PwyAUxYnR6Jx-BA2PvnTyp3StL2apcxoXNVGfCWV0xaxQgc347aVxLvpELpx77rn8ADjDaIQxyy8RQnnC0jEZlZPHhJAEp1m2BwaY0TwZpynbB4Od5ggce_8eS4YROwRHlI0RyQs8AOb5nj5os4ShUXBqNtpZ0yoTYG0dnDn7GZor2GvgRAa9EUFbA2-c3igPX50wXjrdBdsqWDbCLPvbRgT4su466wJ8MtIuldFy63UCDmqx8up0ew7B2-30tbxL5k-z-3IyTyQl4yxRguVUpmlFYlXEdQu0kFjQqhK0LmiVYpRVBUIFrrFShZC4wlnO8gWr62KhUjoE1z--3bpq1ULGjZxY8c7pVrgvboXm_1-MbvjSbjhGNLrGTxyCi62Dsx9r5QNvtZdqtRJG2bXnJIvJSMzXS9mPVDrrvVP1bg5GvIfFexC8B8EjLE4I72HFvvO_IXddv3ToNzigkXM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2676922275</pqid></control><display><type>article</type><title>PI3King the Environment for Growth: PI3K Activation Drives Transcriptome Changes That Support Oncogenic Growth</title><source>MEDLINE</source><source>American Association for Cancer Research</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Claridge, Sally E ; Hopkins, Benjamin D</creator><creatorcontrib>Claridge, Sally E ; Hopkins, Benjamin D</creatorcontrib><description>PI3K signaling plays an integral role in cells, coordinating the necessary alterations in cellular metabolism and programs to support survival and proliferation. In the first genome-wide analysis of alternative splicing in PIK3CA-mutant breast cancer, Ladewig and colleagues show that activating mutations in PIK3CA alter the use of known exons and splice junctions, leading to changes in gene expression and transcription factor activity that promote an oncogenic phenotype. Their work reveals a novel mechanism underlying the functional impact of PI3K signal activation in the context of breast cancer, where PIK3CA mutations are common and PI3K inhibitors are part of the standard of care. Their studies uncover a feedforward mechanism by which PI3K signaling enables a shift in the spectrum of translated splice variants as another method through which the PI3K pathway has evolved to regulate its own activity, thereby modifying the cellular response to upstream activation based on the signaling that has come before. These findings have profound implications for understanding the evolution of the PI3K pathway and the rewiring of cells in response to prolonged or repeated signal activation. See related article by Ladewig et al., p. 2269.</description><identifier>ISSN: 0008-5472</identifier><identifier>ISSN: 1538-7445</identifier><identifier>EISSN: 1538-7445</identifier><identifier>DOI: 10.1158/0008-5472.CAN-22-1466</identifier><identifier>PMID: 35702891</identifier><language>eng</language><publisher>United States</publisher><subject>Breast Neoplasms - genetics ; Breast Neoplasms - metabolism ; Cell Line, Tumor ; Class I Phosphatidylinositol 3-Kinases - antagonists & inhibitors ; Female ; Humans ; Mutation ; Phosphatidylinositol 3-Kinases - genetics ; Phosphatidylinositol 3-Kinases - metabolism ; RNA Splicing ; Transcriptome</subject><ispartof>Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12), p.2216-2218</ispartof><rights>2022 American Association for Cancer Research.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3276-ea583c44b2276915890dc1a3bba3f93b4106b90091f1ee9ac1b16858d5ff9de43</citedby><cites>FETCH-LOGICAL-c3276-ea583c44b2276915890dc1a3bba3f93b4106b90091f1ee9ac1b16858d5ff9de43</cites><orcidid>0000-0002-2539-0178</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,3356,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35702891$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Claridge, Sally E</creatorcontrib><creatorcontrib>Hopkins, Benjamin D</creatorcontrib><title>PI3King the Environment for Growth: PI3K Activation Drives Transcriptome Changes That Support Oncogenic Growth</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>PI3K signaling plays an integral role in cells, coordinating the necessary alterations in cellular metabolism and programs to support survival and proliferation. In the first genome-wide analysis of alternative splicing in PIK3CA-mutant breast cancer, Ladewig and colleagues show that activating mutations in PIK3CA alter the use of known exons and splice junctions, leading to changes in gene expression and transcription factor activity that promote an oncogenic phenotype. Their work reveals a novel mechanism underlying the functional impact of PI3K signal activation in the context of breast cancer, where PIK3CA mutations are common and PI3K inhibitors are part of the standard of care. Their studies uncover a feedforward mechanism by which PI3K signaling enables a shift in the spectrum of translated splice variants as another method through which the PI3K pathway has evolved to regulate its own activity, thereby modifying the cellular response to upstream activation based on the signaling that has come before. These findings have profound implications for understanding the evolution of the PI3K pathway and the rewiring of cells in response to prolonged or repeated signal activation. See related article by Ladewig et al., p. 2269.</description><subject>Breast Neoplasms - genetics</subject><subject>Breast Neoplasms - metabolism</subject><subject>Cell Line, Tumor</subject><subject>Class I Phosphatidylinositol 3-Kinases - antagonists & inhibitors</subject><subject>Female</subject><subject>Humans</subject><subject>Mutation</subject><subject>Phosphatidylinositol 3-Kinases - genetics</subject><subject>Phosphatidylinositol 3-Kinases - metabolism</subject><subject>RNA Splicing</subject><subject>Transcriptome</subject><issn>0008-5472</issn><issn>1538-7445</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkV9PwyAUxYnR6Jx-BA2PvnTyp3StL2apcxoXNVGfCWV0xaxQgc347aVxLvpELpx77rn8ADjDaIQxyy8RQnnC0jEZlZPHhJAEp1m2BwaY0TwZpynbB4Od5ggce_8eS4YROwRHlI0RyQs8AOb5nj5os4ShUXBqNtpZ0yoTYG0dnDn7GZor2GvgRAa9EUFbA2-c3igPX50wXjrdBdsqWDbCLPvbRgT4su466wJ8MtIuldFy63UCDmqx8up0ew7B2-30tbxL5k-z-3IyTyQl4yxRguVUpmlFYlXEdQu0kFjQqhK0LmiVYpRVBUIFrrFShZC4wlnO8gWr62KhUjoE1z--3bpq1ULGjZxY8c7pVrgvboXm_1-MbvjSbjhGNLrGTxyCi62Dsx9r5QNvtZdqtRJG2bXnJIvJSMzXS9mPVDrrvVP1bg5GvIfFexC8B8EjLE4I72HFvvO_IXddv3ToNzigkXM</recordid><startdate>20220615</startdate><enddate>20220615</enddate><creator>Claridge, Sally E</creator><creator>Hopkins, Benjamin D</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2539-0178</orcidid></search><sort><creationdate>20220615</creationdate><title>PI3King the Environment for Growth: PI3K Activation Drives Transcriptome Changes That Support Oncogenic Growth</title><author>Claridge, Sally E ; Hopkins, Benjamin D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3276-ea583c44b2276915890dc1a3bba3f93b4106b90091f1ee9ac1b16858d5ff9de43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Breast Neoplasms - genetics</topic><topic>Breast Neoplasms - metabolism</topic><topic>Cell Line, Tumor</topic><topic>Class I Phosphatidylinositol 3-Kinases - antagonists & inhibitors</topic><topic>Female</topic><topic>Humans</topic><topic>Mutation</topic><topic>Phosphatidylinositol 3-Kinases - genetics</topic><topic>Phosphatidylinositol 3-Kinases - metabolism</topic><topic>RNA Splicing</topic><topic>Transcriptome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Claridge, Sally E</creatorcontrib><creatorcontrib>Hopkins, Benjamin D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Claridge, Sally E</au><au>Hopkins, Benjamin D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PI3King the Environment for Growth: PI3K Activation Drives Transcriptome Changes That Support Oncogenic Growth</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>2022-06-15</date><risdate>2022</risdate><volume>82</volume><issue>12</issue><spage>2216</spage><epage>2218</epage><pages>2216-2218</pages><issn>0008-5472</issn><issn>1538-7445</issn><eissn>1538-7445</eissn><abstract>PI3K signaling plays an integral role in cells, coordinating the necessary alterations in cellular metabolism and programs to support survival and proliferation. In the first genome-wide analysis of alternative splicing in PIK3CA-mutant breast cancer, Ladewig and colleagues show that activating mutations in PIK3CA alter the use of known exons and splice junctions, leading to changes in gene expression and transcription factor activity that promote an oncogenic phenotype. Their work reveals a novel mechanism underlying the functional impact of PI3K signal activation in the context of breast cancer, where PIK3CA mutations are common and PI3K inhibitors are part of the standard of care. Their studies uncover a feedforward mechanism by which PI3K signaling enables a shift in the spectrum of translated splice variants as another method through which the PI3K pathway has evolved to regulate its own activity, thereby modifying the cellular response to upstream activation based on the signaling that has come before. These findings have profound implications for understanding the evolution of the PI3K pathway and the rewiring of cells in response to prolonged or repeated signal activation. See related article by Ladewig et al., p. 2269.</abstract><cop>United States</cop><pmid>35702891</pmid><doi>10.1158/0008-5472.CAN-22-1466</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-2539-0178</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-5472 |
ispartof | Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12), p.2216-2218 |
issn | 0008-5472 1538-7445 1538-7445 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10309115 |
source | MEDLINE; American Association for Cancer Research; EZB-FREE-00999 freely available EZB journals |
subjects | Breast Neoplasms - genetics Breast Neoplasms - metabolism Cell Line, Tumor Class I Phosphatidylinositol 3-Kinases - antagonists & inhibitors Female Humans Mutation Phosphatidylinositol 3-Kinases - genetics Phosphatidylinositol 3-Kinases - metabolism RNA Splicing Transcriptome |
title | PI3King the Environment for Growth: PI3K Activation Drives Transcriptome Changes That Support Oncogenic Growth |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T16%3A10%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PI3King%20the%20Environment%20for%20Growth:%20PI3K%20Activation%20Drives%20Transcriptome%20Changes%20That%20Support%20Oncogenic%20Growth&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=Claridge,%20Sally%20E&rft.date=2022-06-15&rft.volume=82&rft.issue=12&rft.spage=2216&rft.epage=2218&rft.pages=2216-2218&rft.issn=0008-5472&rft.eissn=1538-7445&rft_id=info:doi/10.1158/0008-5472.CAN-22-1466&rft_dat=%3Cproquest_pubme%3E2676922275%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2676922275&rft_id=info:pmid/35702891&rfr_iscdi=true |